{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:54:42Z","timestamp":1793685282755,"version":"4.5.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jaci.2013.12.1088","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T01:07:09Z","timestamp":1393549629000},"page":"621-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":511,"title":["Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens"],"prefix":"10.1016","volume":"133","author":[{"given":"M\u00fcbeccel","family":"Akdis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezmi A.","family":"Akdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.12.1088_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology\/European Academy of Allergy and Clinical Immunology\/PRACTALL consensus report","volume":"131","author":"Burks","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/all.12180","article-title":"Allergen\u00a0immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL consensus report","volume":"68","author":"Calderon","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2013.02.044","article-title":"Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials","volume":"132","author":"Bae","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib4","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2013.2049","article-title":"Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review","volume":"309","author":"Lin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2013.12.1088_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaci.2012.10.058","article-title":"Can we produce true tolerance in patients with food allergy?","volume":"131","author":"Berin","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm.2754","article-title":"Therapies for allergic inflammation: refining strategies to induce tolerance","volume":"18","author":"Akdis","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib7","first-page":"718","article-title":"Allergy and hypersensitivity: mechanisms of allergic disease","volume":"18","author":"Akdis","year":"2006","journal-title":"Curr\u00a0Opin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib8","series-title":"Middleton\u2019s allergy: principles and practice","article-title":"Immune tolerance","author":"Akdis","year":"2013"},{"key":"10.1016\/j.jaci.2013.12.1088_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaci.2009.10.035","article-title":"Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet","volume":"125","author":"Durham","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrd2653","article-title":"Therapeutic manipulation of immune tolerance in allergic disease","volume":"8","author":"Akdis","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2013.12.1088_bib11","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1084\/jem.20080193","article-title":"In\u00a0vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure","volume":"205","author":"Meiler","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.2011.01021.x","article-title":"Allergens and their role in the allergic immune response","volume":"242","author":"Platts-Mills","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2013.12.1088_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2332\/allergolint.13-RAI-0608","article-title":"Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development","volume":"62","author":"Jutel","year":"2013","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2013.12.1088_bib14","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jaci.2012.05.003","article-title":"TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection","volume":"129","author":"Akdis","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1615\/CritRevImmunol.2013007046","article-title":"Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases","volume":"33","author":"Smarr","year":"2013","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","article-title":"Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome","volume":"127","author":"Lotvall","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl","key":"10.1016\/j.jaci.2013.12.1088_bib19","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaci.2010.11.047","article-title":"Diagnosis and management of drug hypersensitivity reactions","volume":"127","author":"Romano","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2222.1995.tb00007.x","article-title":"Tryptase and histamine\u00a0release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization","volume":"25","author":"Eberlein-Konig","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000095461","article-title":"Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy","volume":"141","author":"Plewako","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaci.2012.04.039","article-title":"Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2","volume":"130","author":"Novak","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","article-title":"Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies","volume":"127","author":"James","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1365-2222.2011.03794.x","article-title":"Immunotherapy for allergic rhinitis","volume":"41","author":"Walker","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","article-title":"Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors","volume":"63","author":"Meiler","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/eji.200425523","article-title":"Regulation\u00a0of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26","volume":"36","author":"Oral","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib29","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.154.8.4187","article-title":"Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen stimulated T cell cultures","volume":"154","author":"Jutel","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-b cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20032058","article-title":"Immune responses in healthy and allergic Individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells","volume":"199","author":"Akdis","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1067\/mai.2003.1570","article-title":"Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy","volume":"111","author":"Francis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2222.1997.tb00674.x","article-title":"Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy","volume":"27","author":"Van Ree","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib35","first-page":"456","article-title":"Specific IgE response with a standardized allergen or allergoid in grass pollen allergy","volume":"56","author":"Bousquet","year":"1986","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0091-6749(82)90062-8","article-title":"Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study","volume":"70","author":"Gleich","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1172\/JCI107204","article-title":"IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy","volume":"52","author":"Lichtenstein","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0091-6749(88)90017-6","article-title":"Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy","volume":"82","author":"Bousquet","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000073260","article-title":"Renaissance of the blocking antibody concept in type I allergy","volume":"132","author":"Flicker","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib40","first-page":"313","article-title":"Mechanisms of immunotherapy: IgG revisited","volume":"4","author":"Wachholz","year":"2004","journal-title":"Curr\u00a0Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0091-6749(82)90172-5","article-title":"Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy","volume":"69","author":"Golden","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1398-9995.1989.tb04172.x","article-title":"Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom","volume":"44","author":"M\u00fcller","year":"1989","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib43","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.4049\/jimmunol.172.5.3252","article-title":"Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity","volume":"172","author":"Nouri-Aria","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaci.2005.06.004","article-title":"Allergen-specific immunotherapy with recombinant grass pollen allergens","volume":"116","author":"Jutel","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2222.1989.tb02405.x","article-title":"Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus)","volume":"19","author":"Van Bever","year":"1989","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0091-6749(88)90021-8","article-title":"The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients","volume":"82","author":"Rak","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2222.1997.tb01225.x","article-title":"Clinical\u00a0efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial","volume":"27","author":"Varney","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0091-6749(97)70084-8","article-title":"Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy","volume":"99","author":"Hakansson","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib49","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1172\/JCI112233","article-title":"Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy","volume":"76","author":"Creticos","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/02770909509089497","article-title":"Decreased production of endothelin-1 in asthmatic children after immunotherapy","volume":"32","author":"Chen","year":"1995","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2013.12.1088_bib51","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.146.6.1829","article-title":"T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma","volume":"146","author":"Walker","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib52","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.143.4.1310","article-title":"Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids","volume":"143","author":"Schleimer","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/cimm.2000.1739","article-title":"Antigen-specific T cell tolerance down-regulates mast cell responses in\u00a0vivo","volume":"206","author":"Treter","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2222.2003.01567.x","article-title":"Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability","volume":"33","author":"Shim","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI118506","article-title":"Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells","volume":"97","author":"Marshall","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib56","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.4049\/jimmunol.152.9.4368","article-title":"B7\/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10","volume":"152","author":"Schandane","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib57","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1172\/JCI118603","article-title":"CD40 expression by human peripheral blood eosinophils","volume":"97","author":"Ohkawara","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib58","first-page":"170","article-title":"A disquisition on suppressor T cells","volume":"26","author":"Gershon","year":"1975","journal-title":"Transplant Rev"},{"key":"10.1016\/j.jaci.2013.12.1088_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10772","article-title":"Extrathymically generated regulatory T cells control mucosal TH2 inflammation","volume":"482","author":"Josefowicz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.12.1088_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-065X.1996.tb00906.x","article-title":"Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity","volume":"149","author":"Strober","year":"1996","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2013.12.1088_bib61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2013.07.030","article-title":"Natural killer cells in patients with allergic diseases","volume":"132","author":"Deniz","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/all.12133","article-title":"Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides","volume":"68","author":"Sackesen","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib64","first-page":"816","article-title":"Regulatory T cells in the control of immune pathology","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat\u00a0Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri1032","article-title":"Natural versus adaptive regulatory T cells","volume":"3","author":"Bluestone","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib66","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O'Garra","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/86302","article-title":"Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide","volume":"2","author":"Jordan","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib68","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib69","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of\u00a0peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri1589","article-title":"Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma","volume":"5","author":"Hawrylowicz","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib71","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI200320274","article-title":"The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery","volume":"112","author":"Sakaguchi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.12.1088_bib74","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1084\/jem.20090596","article-title":"Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells","volume":"206","author":"Klunker","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib75","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2013.12.1088_bib77","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaci.2007.05.036","article-title":"Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects","volume":"120","author":"Orihara","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib78","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20061660","article-title":"Plasmacytoid\u00a0dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand","volume":"204","author":"Ito","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.12.1088_bib81","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.4049\/jimmunol.181.8.5396","article-title":"The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib82","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jaci.2012.10.051","article-title":"Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood","volume":"131","author":"Kucuksezer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib83","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2011.09.031","article-title":"Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance","volume":"129","author":"Palomares","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib84","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1371\/journal.pbio.0050329","article-title":"GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells","volume":"5","author":"Mantel","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib85","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcp.21001","article-title":"The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road","volume":"211","author":"Zhang","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.12.1088_bib87","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2012.02.014","article-title":"A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy","volume":"129","author":"Zimmer","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib89","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1286-4579(99)00250-6","article-title":"TGF-beta and fibrosis","volume":"1","author":"Branton","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jaci.2013.12.1088_bib90","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaci.2007.04.004","article-title":"IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1","volume":"120","author":"Taylor","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib91","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A","article-title":"IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway","volume":"30","author":"Joss","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib92","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.molimm.2008.07.031","article-title":"IL-10 suppresses CD2-mediated T cell activation via SHP-1","volume":"46","author":"Taylor","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib93","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11882-996-0005-8","article-title":"Interleukin-10-secreting regulatory T cells in allergy and asthma","volume":"6","author":"Urry","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2013.12.1088_bib94","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaci.2011.06.051","article-title":"Regulation of the immune response and inflammation by histamine and histamine receptors","volume":"128","author":"O'Mahony","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib95","first-page":"G987","article-title":"Novel insights into histamine H2 receptor biology","volume":"273","author":"Del Valle","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib96","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/35096564","article-title":"Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors","volume":"413","author":"Jutel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.12.1088_bib97","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI200113930","article-title":"Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization","volume":"108","author":"Mazzoni","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.12.1088_bib98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00268-X","article-title":"Regulation of interleukin-10 secretion by\u00a0histamine in TH2 cells and splenocytes","volume":"1","author":"Osna","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib99","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1096\/fj.02-1008com","article-title":"Histamine enhances TGF-beta1-mediated suppression of Th2 responses","volume":"17","author":"Kunzmann","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2013.12.1088_bib100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1398-9995.2005.00699.x","article-title":"Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis","volume":"60","author":"Wilson","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib101","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1398-9995.2011.02583.x","article-title":"Systematic reviews of sublingual immunotherapy (SLIT)","volume":"66","author":"Radulovic","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib102","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000083956","article-title":"Impact\u00a0of sublingual immunotherapy on specific antibody levels in asthmatic\u00a0children allergic to house dust mites","volume":"136","author":"Bahceciler","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib103","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1081-1206(10)61186-6","article-title":"Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report","volume":"95","author":"Ciprandi","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000083320","article-title":"Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen","volume":"136","author":"Rolinck-Werninghaus","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.12.1088_bib105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1398-9995.2006.01206.x","article-title":"Sublingual immunotherapy in children modulates allergen-induced in\u00a0vitro expression of cytokine mRNA in PBMC","volume":"61","author":"Savolainen","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib106","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1034\/j.1398-9995.2001.056003231.x","article-title":"Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma","volume":"56","author":"Marcucci","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.12.1088_bib107","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1034\/j.1398-9995.2003.00193.x","article-title":"Effects\u00a0on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites","volume":"58","author":"Marcucci","year":"2003","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:46:01Z","timestamp":1758789961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674914001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0091674914001067"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1088","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}